Evolution AB Stock Performance

EVGGF Stock  USD 61.82  -1.30  -2.06%   
The company secures a market beta of 1.33, which conveys elevated sensitivity to broad market movements. Market upswings tend to lift Evolution more than average, but downturns carry a proportionally larger impact on returns. At this point, Evolution AB has a negative expected return of -0.066%.
Risk-Adjusted Performance
Weak
 
Weak
 
Strong
Over the last 90 days, Evolution AB generated negative risk-adjusted returns and added little value for investors with long positions. Used correctly, this score supports evaluation of raw price movement versus actual return efficiency. Despite nearly stable technical and fundamental indicators, Evolution is not utilizing all of its potential. The current price disturbance may contribute to mid-run losses for stockholders. Learn More
Begin Period Cash Flow221.7 M
Total Cashflows From Investing Activities-155 M
  

Relative Risk vs. Return Landscape

If you had invested $ 6,646 in Evolution AB on December 22, 2025 and sold it today you would have lost $ 464.00 from holding Evolution AB or given up 6.98% of portfolio value over 90 days. Evolution AB is currently producing negative expected returns and carries 3.1965% volatility of returns over 90 trading days. Put another way, 28% of traded pink sheets are less volatile than Evolution, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
This comparison focuses on expected return, realized volatility, and risk efficiency versus the market. It is most useful when expected return is read together with volatility rather than in isolation. Assuming a 90-day horizon Evolution is expected to generate 3.91 times more return on investment than the market. However, the company is 3.91 times more volatile than its market benchmark. It trades about -0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.11 per unit of risk.

Target Price Odds to finish over Current Price

Investors have long observed that Evolution Pink Sheet price tends to fluctuate around a central value over time. This mean reversion pattern is a cornerstone of many forecasting models. However, periods of persistent mispricing in some stocks suggest that additional risk factors may account for the delayed correction.
Current PriceHorizonTarget PriceOdds moving above the current price in 90 days
61.82 90 days 61.82
about 76.26
A normal distribution analysis suggests that the odds of Evolution moving above the current price in 90 days from now are about 76.26 (The distribution above shows where Evolution Pink Sheet price is most likely to fall within the next 90 days based on historical volatility).
Assuming a 90-day horizon the pink sheet has the beta coefficient of 1.33 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Evolution will likely underperform. Additionally, Evolution AB has an alpha of 0.0155, implying that it can generate a 0.0155 percent excess return over Dow Jones Industrial after adjusting for the inherent market risk (beta).
   Evolution Price Density   
       Price  

Predictive Modules for Evolution

Forecasting Evolution AB involves applying various models to estimate future price behavior. While no method can consistently predict the pink sheet market with certainty, the discipline of building and testing forecasts sharpens investment thinking. Combining several approaches and cross-checking results offers a more balanced view of potential outcomes.
Mean reversion in Evolution's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Hype
Prediction
LowEstimatedHigh
58.6261.8265.02
Details
Intrinsic
Valuation
LowRealHigh
49.4052.6068.00
Details
Naive
Forecast
LowNextHigh
58.2561.4564.64
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
57.3461.0364.73
Details
A rigorous investment case for Evolution requires more than studying its own financials. Benchmarking Evolution's performance, valuation, and risk profile against competitors is essential to validate any investment thesis.

Primary Risk Indicators

The pink sheet market has gone through extended periods of turbulence over the past two decades. Evolution has not been immune to these swings. Sudden corrections and sharp rallies have tested many portfolios. Investors can protect against downside risk in Evolution AB by monitoring Evolution's fundamental risk indicators and maintaining appropriate hedges.
α
Alpha over Dow Jones
0.02
β
Beta against Dow Jones1.33
σ
Overall volatility
3.54
Ir
Information ratio -0.0055

Investor Alerts and Insights

Setting up alerts on Evolution ensures that material changes in technical or fundamental conditions are not missed. These notifications for Evolution AB help investors make timely decisions in response to significant stock events.
Evolution AB generated a negative expected return over the last 90 days
Evolution AB has high historical volatility and very poor performance
About 17.0% of the company shares are held by company insiders

Evolution Fundamentals Growth

Evolution's fundamentals serve as the primary lens through which investors evaluate Evolution Pink Sheet. Metrics such as earnings growth, revenue consistency, margin trends, and balance sheet strength collectively determine market sentiment toward Evolution Pink Sheet.

Performance Metrics & Calculation Methodology

Evolution performance is measured on a risk-adjusted basis against benchmarks. Drawdown profile frames downside sensitivity and recovery characteristics. Evolution shows ROE of 25.36%, ROA of 13.72%.

This section for Evolution AB is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules. Return and risk statistics are calculated from historical price series.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 18th, 2026